First Author | Elenbaas JS | Year | 2023 |
Journal | Nat Commun | Volume | 14 |
Issue | 1 | Pages | 850 |
PubMed ID | 36792666 | Mgi Jnum | J:333810 |
Mgi Id | MGI:7436889 | Doi | 10.1038/s41467-023-36486-0 |
Citation | Elenbaas JS, et al. (2023) SVEP1 is an endogenous ligand for the orphan receptor PEAR1. Nat Commun 14(1):850 |
abstractText | Sushi, von Willebrand factor type A, EGF and pentraxin domain containing 1 (SVEP1) is an extracellular matrix protein that causally promotes vascular disease and associates with platelet reactivity in humans. Here, using a human genomic and proteomic approach, we identify a high affinity, disease-relevant, and potentially targetable interaction between SVEP1 and the orphan receptor Platelet and Endothelial Aggregation Receptor 1 (PEAR1). This interaction promotes PEAR1 phosphorylation and disease associated AKT/mTOR signaling in vascular cells and platelets. Mice lacking SVEP1 have reduced platelet activation, and exogenous SVEP1 induces PEAR1-dependent activation of platelets. SVEP1 and PEAR1 causally and concordantly relate to platelet phenotypes and cardiovascular disease in humans, as determined by Mendelian Randomization. Targeting this receptor-ligand interaction may be a viable therapeutic strategy to treat or prevent cardiovascular and thrombotic disease. |